-
MVdeltaC Receives FDA Orphan Drug Designation in Pleural Mesothelioma
12 Jun 2025 22:10 GMT
… improve clinical outcomes in patients with advanced solid tumors like pleural mesothelioma … human tumor cell lines, including mesothelioma, lung adenocarcinoma, hepatocarcinoma, and … findings, a first-in-human clinical trial is being planned for patients …
-
Oncovita secures US FDA orphan drug designation for its lead oncolytic virus candidate, MVdeltaC to treat pleural mesothelioma
07 Jun 2025 09:46 GMT
… advanced solid tumors, including pleural mesothelioma.
“Receiving Orphan Drug Designation from … including tax credits for eligible clinical trials, waiver of US FDA application … following product approval.
Pleural mesothelioma is a rare and aggressive …
-
HITHOC for Mesothelioma May Be More Effective Than Surgery Alone
06 Jun 2025 22:38 GMT
… more clinical trials to better understand how HITHOC compares with other mesothelioma treatments … and often as part of clinical trials. A mesothelioma specialist can help determine …
-
MVdeltaC Earns Orphan Drug Status for Pleural Mesothelioma
06 Jun 2025 17:23 GMT
… , and tax credits toward qualifying clinical trials.
“With this designation, Oncovita … destruction with immune stimulation.
Pleural mesothelioma is a rare, aggressive cancer … dosing controlled tumor growth in mesothelioma and bladder cancer.
In …
-
Guest Editorial – The national mesothelioma registry: A path to better care for Linn County’s veterans
05 Jun 2025 18:14 GMT
… treatment are limited. Furthermore, as mesothelioma first manifests with non-specific … number of patients for conducting clinical trials that improve diagnosis rates and … the implementation of the National Mesothelioma Registry. By raising awareness, …
-
BNT327/PM8002 Plus Chemo Is Active in Unresectable Pleural and Peritoneal Mesothelioma
04 Jun 2025 19:14 GMT
… has demonstrated early signals of clinical activity and a tolerable safety … for patients with malignant mesothelioma.
Diving into the Trial Design
The present … status of 1 (80.6%). Clinical stage II, III, and IV …
-
Oncovita receives FDA Orphan Drug Designation for its lead oncolytic virus candidate MVdeltaC in the treatment of pleural mesothelioma
04 Jun 2025 13:00 GMT
… advanced solid tumors, including pleural mesothelioma.
“Receiving Orphan Drug Designation from … , including tax credits for eligible clinical trials, waiver of FDA application fees … 76 82 83 About Pleural Mesothelioma Pleural mesothelioma is a rare and …
-
Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting
31 May 2025 19:22 GMT
… open-label, controlled Phase 3 clinical trial designed to test the efficacy … , multi-center, Phase 2 clinical trial designed to test the safety … pleural mesothelioma and pleural mesothelioma. Novocure has several additional ongoing or completed clinical trials …
-
Results From the Phase 3 PANOVA-3 Trial of Novocure’s Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting
31 May 2025 12:30 GMT
… multi-center, Phase 2 clinical trial designed to test the safety … mesothelioma and pleural mesothelioma. Novocure has several additional ongoing or completed clinical trials … on its research programs, clinical trial progress, development of potential …
-
Niraparib Extends Life for Mesothelioma Patients, NERO Trial Finds
31 May 2025 00:04 GMT
… mesothelioma, a rare and aggressive cancer caused by asbestos exposure.
The clinical trial … the Cancer Research UK Southampton Clinical Trials Unit (SCTU), with funding … improve progression-free survival for mesothelioma,” explained Professor Gareth Griffins, …
About
© 1995-2025